cell

Genmab Announces Epcoritamab Investigational Combination Therapy Demonstrates High Response Rates in Patients with Relapsed or Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL) Eligible for Autologous Stem Cell Transplantation (ASCT)

Media ReleaseCOPENHAGEN, Denmark; June 15, 2025 Results from the EPCORE® NHL-2 trial show investigational treatment with epcoritamab in combination with…

8 months ago

Highstar Unveils Next-Gen Tabless Cell Series at The Battery Show Europe 2025

STUTTGART, Germany, June 5, 2025  /PRNewswire/ -- Highstar launched its next-generation Tabless Cell series under the theme "Tabless Forest, Vitality Reborn"…

8 months ago

Alkegen Enters Full Production of EV Battery Fire Protection Aerogels

World's Largest Supplier of Cell Spacers Delivering OEMs a Full Portfolio of Advanced Thermal Solutions IRVING, Texas, June 4, 2025…

8 months ago